TIDMAVCT

Avacta Group PLC

04 August 2014

4 August 2014

Avacta Group plc

("Avacta" or the "Group")

New OPTIM Software and Hardware

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces that Avacta Analytical has completed the development of two new OPTIM variants. Alongside this, the Group has released upgraded OPTIM software, intended to widen the range of potential customers.

OPTIM, Avacta Analytical's protein characterisation instrument, was launched during 2010 as OPTIM 1000 and was substantially redeveloped into the OPTIM2 system during 2013. Designed to reduce the time and cost of therapeutic protein development, the OPTIM instruments can provide multiple protein stability-indications at high speed using ultra-low sample volumes.

Avacta has completed the development of upgraded software for the OPTIM platform, expanding the capabilities available to end users. Two new variants to the core OPTIM platform, OPTIM 375 and OPTIM 445, which incorporate incremental measurement capabilities are now available. The Directors consider that these two new variants and the related upgraded software widen the appeal of OPTIM in its core drug development market by focusing on applications to characterise the viscosity of samples and the stability of membrane protein targets.

Alastair Smith, Avacta Group Chief Executive of Avacta said: "Now that OPTIM is becoming established as a valuable tool for protein stability characterisation, we are working hard to expand the range of applications and measurement types that the system can support in order to broaden the instrument's market appeal and drive consumable usage. The latest developments are in response to the market demand, which is growing worldwide, that we have identified for viscosity determination on small samples and for stability characterisation of membrane protein targets which are a challenging but important class of protein samples."

Enquiries:

 
 Avacta Group plc                                 Tel: +44 (0) 844 414 
  Alastair Smith, Chief Executive Officer          0452 
  Tim Sykes, Chief Financial Officer               www.avacta.com 
 
 Numis Securities Limited                         Tel: +44 (0) 207 260 
  Michael Meade / Freddie Barnfield - Nominated    1000 
  Adviser                                          www.numiscorp.com 
  James Black - Corporate Broking 
 
 Media Enquiries                                             Tel: +44 (0) 207 933 
  Walbrook PR Ltd                                             8780 
  Mike Wort / Anna Dunphy                                     avacta@walbrookpr.com

About Avacta Group plc - www.avacta.com

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

 
            Avacta Analytical             High throughput analysis instrument, Optim, 
             www.avactaanalytical.com      to help reduce the cost and risk of drug development. 
            Avacta Animal Health          Veterinary diagnostics reference laboratory, 
             www.avactaanimalhealth.com    diagnostic kits and newly launched in-clinic 
                                           blood analyser, Sensipod. 
                                         ------------------------------------------------------- 
            Avacta Life Sciences          Novel non-antibody affinity reagents called 
             www.avactalifesciences.com    Affimers, with a wide range of Life Science 
                                           applications in diagnostics, drug and biomarker 
                                           discover and biotech research and development. 
                                         -------------------------------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRADMGGRKMZGDZM

Avacta (LSE:AVCT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Avacta Charts.
Avacta (LSE:AVCT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Avacta Charts.